J&J Stock Sinks After Revenue Misses and Full-year Outlook Was Cut, as Drug Sales Disappoint

Jason Ware, Partner & Chief Investment Officer at Albion Financial Group, talks about the growth prospects for the healthcare industry and highlights areas in the market that are undervalued.

Apr 20, 2022

More Videos

Hershey’s Meets KATSEYE: Inside the Brand’s Gen Z Strategy

Dan Mohshine, Hershey’s VP of Demand Creation Strategy & Innovation, discusses the brand’s premium chocolate push and strategy to connect with younger consumers

Why Ouster CEO Says It's John Deere’s Partnership Could Change the Game For Autonomous Farming

Angus Pacala, CEO of Ouster, breaks down what the John Deere deal means, how lidar will work in machines, and what’s next for autonomy.

How Roblox Is Turning Young Gamers into Entrepreneurs

Rush Bogin, top Roblox creator explains how the platform is turning young creators into entrepreneurs and building a booming digital economy.

Remember Napster? Now It’s Making a Wild AI Comeback

Napster CEO John Acunto explains how the iconic brand is reinventing itself as an AI company using video agents to transform customer experiences.

Meta Is Paying Billions: What Exactly Is The Company Agreeing To?

Tyler Katzenberger, Technology Reporter at POLITICO, breaks down what Meta is agreeing to in its multibillion-dollar settlements and why they matter.

Why These People Made the TIME100 AI List

Ayesha Javed, senior editor at TIME, takes us inside the selection and explains what the list reveals about the future of artificial intelligence.

Why Everyone Went Back to the Movies This Summer

Screen Engine CEO Kevin Goetz reveals what audience research says about Hollywood’s surprising 2026 box-office rebound.

Is Whatnot Turning Shopping into Gambling? Inside the App’s Addictive Live Auctions

Hanna Krueger, Wall Street Journal reporter, examines Whatnot’s fast-paced auctions, impulse spending and gambling-like shopping experience.